Skip to main content
. Author manuscript; available in PMC: 2016 Oct 1.
Published in final edited form as: J Subst Abuse Treat. 2015 Apr 13;57:18–29. doi: 10.1016/j.jsat.2015.04.003

Figure 1. Intensity of Dissemination and Clinician and Clinic Characteristics Affect Stages of the Innovation-decision Process.

Figure 1

Standardized regression coefficients are significant (p < .001) unless marked not significant (ns). Solid lines represent direct paths between stage variables. Dotted lines represent direct paths from clinician and clinic characteristics to stage variables. Clinician and clinic characteristics noted with a capital letter have a significant (p < .05) direct effect on the stage variable with the same capital letter; these coefficients are presented in Table 2.